Trials / Completed
CompletedNCT00250315
DOCICAR: Cardiac Dysfunction in Cirrhosis
Cardiac Dysfunction in Cirrhosis: Cirrhotic Cardiomyopathy Evaluated by Dobutamin MRI.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- —
- Sponsor
- Hvidovre University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Patients with cirrhosis have a altered cardiac response to stress. This study evaluate the cardiac response by MRI during dobutamine stress. Hypothesis: impared increase in cardiac output, cardiac index, ejection fraction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dobutamine |
Timeline
- Start date
- 2005-11-01
- Completion
- 2007-10-01
- First posted
- 2005-11-08
- Last updated
- 2007-11-01
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00250315. Inclusion in this directory is not an endorsement.